MYGN - Myriad Genetics Inc - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
5/15/24 17:49	5/13/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Diaz Paul J	UT	DO	P,CEO	S.m	-5,729	25.14	-228	-18	1,066	D
5/15/24 17:48	5/13/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Newcomer Lee Nisley	UT	D		S	-157	25.30	-6	-9	67	D
12/5/23 16:19	12/1/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-573	19.09	-30	-9	292	D
11/3/23 17:12	11/1/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-471	15.69	-30	-9	322	D
6/2/23 18:15	6/2/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-199	23.01	-9	-18	40	D
3/28/23 17:23	3/27/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	COO	S	-151	23.48	-6	-3	241	D
3/3/23 17:07	3/2/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-338	22.55	-15	-4	338	D
3/3/23 17:04	3/2/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	COO	S	-300	22.74	-13	-6	215	D
1/23/23 16:14	1/20/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-188	20.04	-9	-3	364	D
1/19/23 17:56	1/18/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-12	20.01	-1	0	374	D
12/28/22 16:05	12/27/22	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-303	15.15	-20	-5	374	D
6/6/22 19:20	6/6/22	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-124	19.25	-6	-16	34	D
3/1/22 16:55	2/28/22	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Hart Jayne B.	UT	O	Chief Pe	M.d	252	23.98	11	7	166	D
3/1/22 16:55	2/28/22	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Hart Jayne B.	UT	O	Chief Pe	S.d	-263	25.00	-11	-6	166	D
10/4/21 16:16	10/1/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	See Rema	S	-45	31.57	-1	-1	177	D
9/27/21 21:13	9/27/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	See Rema	S	-335	33.10	-10	-5	178	D
9/27/21 19:40	9/23/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lanchbury Jerry S	UT	O	Chief Sc	S	-7	35.06	0	0	275	D
9/21/21 18:18	9/17/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Hart Jayne B.	UT	O	Chief Pe	M.d	2,040	26.49	77	610	90	D
9/21/21 18:18	9/17/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Hart Jayne B.	UT	O	Chief Pe	S.d	-2,274	33.72	-67	-43	90	D
8/30/21 16:11	8/27/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	See Rema	S	-33	34.50	-1	-1	127	D
8/25/21 20:32	8/23/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lanchbury Jerry S	UT	O	Chief Sc	M.dm	2,166	27.07	80	52	233	D
8/25/21 20:32	8/23/21	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lanchbury Jerry S	UT	O	Chief Sc	S.dm	-2,826	35.32	-80	-26	233	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y